Robert D. Schreiber
Barnes-Jewish Hospital · 644 works · 108,260 citations · h-index 129
Top works
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
- HOW CELLS RESPOND TO INTERFERONS
- Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
- Cancer immunoediting: from immunosurveillance to tumor escape
- Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway
- IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
- The Three Es of Cancer Immunoediting
- Neoantigens in cancer immunotherapy
- The Immunobiology of Cancer Immunosurveillance and Immunoediting
- Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor.
- Rapid induction of the expression of proto-oncogene fos during human monocytic differentiation
- Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.
- Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4.
- The Molecular Cell Biology of Interferon-gamma and its Receptor
- Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors.
- Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
- Cancer Immunosurveillance and Immunoediting: The Roles of Immunity in Suppressing Tumor Development and Shaping Tumor Immunogenicity
- Ligand‐induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91).